Glenmark Pharmaceuticals awards UK supply chain to Yusen Logistics

Published: 16-Jun-2017

Yusen Logistics, the award-winning pharmaceutical global logistics specialist, has been awarded a major contract by India-based pharmaceutical manufacturer Glenmark Pharmaceuticals

Glenmark were looking to reduce delivery lead times to their UK customer base, whilst maintaining stringent quality standards for their high-quality generics and specialty products.

The Yusen Logistics solution is based at the company’s 15,000m2 GDP-compliant, MHRA-licenced warehousing facility at Grange Park (Northampton, UK).

The facility provides a high security environment, being both AEO-approved and TAPA-compliant.

Yusen Logistics is now handling all Glenmark product destined for the UK market from the strategically located facility situated within a 4 hour drive of the whole country.

Yusen is providing a comprehensive solution, including temperature controlled pallet storage and pick and pack, as well as managing final mile delivery nationwide in the UK (on a day 1 for day 3 delivery) to wholesalers and pharmacies.

Frank Packman, General Manager Business Development for the Healthcare sector at Yusen Logistics, commented: “Healthcare manufacturers are increasingly searching for high quality, end-to-end solutions to move their products throughout the supply chain, whilst maintaining a stringent temperature regime at all times. Maximising availability of stock, whilst minimising risk in the supply chain are driving demand.”

Yusen Logistics operates a collaborative network servicing final mile distribution requirements across the whole of Europe and beyond in the healthcare sector, providing in-market supply to end users — hospitals, pharmacies, doctors, dentists, wholesalers and vaccination centres.

This service is dedicated solely to the stringent requirements of the pharmaceutical and healthcare industry, with more than 50,000 delivery points.

Yusen currently makes 20,000 deliveries per week across 36 countries.

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
  2. You need to be a subscriber to read this article.
    Click here to find out more.

You may also like